Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Network Comparison Type Rank Gene Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 912 to 961 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
eh-domain containing protein 4 (eh domain-containing protein fksg7) (hepatocellular carcinoma-associated protein 10/11). [source:swissprot;acc:q9h223]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2516\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6203.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6360.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02519\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
eif-5a2 protein. [source:refseq;acc:nm\_020390]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1610\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6222.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6665.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07126\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
elac homolog 2; putative prostate cancer susceptibility protein; elac (e. coli) homolog 2. [source:refseq;acc:nm\_018127]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2206\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5076.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5326.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04916\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
elav-like protein 1 (hu-antigen r) (hur). [source:swissprot;acc:q15717]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2178\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5893.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6193.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05092\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
elav-like protein 2 (hu-antigen b) (hub) (elav-like neuronal protein 1) (nervous system-specific rna binding protein hel-n1). [source:swissprot;acc:q12926]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2180\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5900.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6200.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05084\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
elav-like protein 3 (hu-antigen c) (huc) (paraneoplastic cerebellar degeneration-associated antigen) (paraneoplastic limbic encephalitis antigen 21). [source:swissprot;acc:q14576]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2177\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5887.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6187.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05102\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
elav-like protein 4 (paraneoplastic encephalomyelitis antigen hud) (hu-antigen d). [source:swissprot;acc:p26378]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2179\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5896.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6196.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05089\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
electron transfer flavoprotein alpha-subunit, mitochondrial precursor (alpha-etf). [source:swissprot;acc:p13804]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1749\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7919.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8452.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06721\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
electron transfer flavoprotein beta-subunit (beta-etf). [source:swissprot;acc:p38117]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1761\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7794.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8316.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06692\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial precursor (ec 1.5.5.1) (etf-qo) (etf-ubiquinone oxidoreductase) (etf dehydrogenase) (electron-transferring- flavoprotein dehydrogenase). [source:swissprot;acc:q16134]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1301\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6618.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7161.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08203\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
elks protein. [source:refseq;acc:nm\_015064]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1163\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5832.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6343.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0877\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ell-associated factor 2; uncharacterized bone marrow protein bm040; testosterone regulated apoptosis inducer and tumor suppressor. [source:refseq;acc:nm\_018456]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2921\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
elongation factor 1-alpha 1 (ef-1-alpha-1) (elongation factor 1 a-1) (eef1a-1) (elongation factor tu) (ef-tu). [source:swissprot;acc:p04720]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1733\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5874.83\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6272.26\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06765\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
elongation factor 1-alpha 2 (ef-1-alpha-2) (elongation factor 1 a-2) (eef1a-2) (statin s1). [source:swissprot;acc:q05639]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1735\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
elongation factor 2 (ef-2). [source:swissprot;acc:p13639]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1069\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5494.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6001.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09215\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
elongation factor ts, mitochondrial precursor (ef-ts) (ef-tsmt). [source:swissprot;acc:p43897]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3027\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
elongation of very long chain fatty acids protein 1 (cgi-88). [source:swissprot;acc:q9bw60]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
458\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4890.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5610.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14731\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
elongation protein 4 homolog; pax6 neighbor gene; chromosome 11 open reading frame 19. [source:refseq;acc:nm\_019040]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1344\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5887.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6354.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07925\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
endo-beta-n-acetylglucosaminidase. [source:refseq;acc:nm\_022759]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
520\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9642.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10986.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13941\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
endonuclease g, mitochondrial precursor (ec 3.1.30.-) (endo g). [source:swissprot;acc:q14249]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2695\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5176.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5154.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00436\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
endosome-associated fyve-domain protein. [source:refseq;acc:nm\_014733]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3200\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
endothelial-derived gene 1. [source:refseq;acc:nm\_025205]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1807\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6399.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6818.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06542\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
enhancer of filamentation 1 (hef1) (crk-associated substrate-related protein) (cas-l) (casl) (pp105) (neural precursor cell expressed developmentally down-regulated 9). [source:swissprot;acc:q14511]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
202\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4812.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6076.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26269\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
enhancer of rudimentary homolog. [source:swissprot;acc:q14259]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2072\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6437.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6797.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05592\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
enhancer of zeste homolog 1 (enx-2). [source:swissprot;acc:q92800]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3090\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
enhancer of zeste homolog 2 (enx-1). [source:swissprot;acc:q15910]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3098\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
enigma protein; lim domain protein. [source:refseq;acc:nm\_005451]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1596\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5665.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6070.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07148\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
enoyl-coa hydratase, mitochondrial precursor (ec 4.2.1.17) (short chain enoyl-coa hydratase) (sceh) (enoyl-coa hydratase 1). [source:swissprot;acc:p30084]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
504\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10067.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11511\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14334\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
enteropeptidase precursor (ec 3.4.21.9) (enterokinase). [source:swissprot;acc:p98073]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
347\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4991.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5885.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17914\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
enthoprotin; epsin 4; clathrin interacting protein localized in the trans-golgi region. [source:refseq;acc:nm\_014666]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2022\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5520.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5841.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05813\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
epidermal growth factor receptor kinase substrate eps8. [source:swissprot;acc:q12929]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1261\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5685.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6157.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08305\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
epidermal growth factor receptor pathway substrate 8-like protein 1 isoform c; epidermal growth factor receptor pathway substrate 8-related protein 1; eps8-related protein 1. [source:refseq;acc:nm\_139204]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1259\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5685.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6157.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08308\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
epidermal growth factor receptor pathway substrate 8-like protein 2; eps8-related protein 2; epidermal growth factor receptor pathway substrate 8-related protein 2. [source:refseq;acc:nm\_022772]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1270\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5685.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6156.48\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08292\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
epidermal growth factor receptor precursor (ec 2.7.1.112) (receptor protein-tyrosine kinase erbb-1). [source:swissprot;acc:p00533]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1391\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5743.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6192.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07824\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
epididymal secretory protein e1 precursor (niemann-pick disease type c2 protein) (epi-1) (he1) (epididymal secretory protein 14.6) (esp14.6). [source:swissprot;acc:q15668]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
872\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6781.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7480.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1031\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
epithelial-cadherin precursor (e-cadherin) (uvomorulin) (cadherin-1) (cam 120/80). [source:swissprot;acc:p12830]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2173\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3641.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3462.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05153\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
epoxide hydrolase 1 (ec 3.3.2.3) (microsomal epoxide hydrolase) (epoxide hydratase). [source:swissprot;acc:p07099]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1573\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11785.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10995.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07186\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
epsin 1; eh domain-binding mitotic phosphoprotein. [source:refseq;acc:nm\_013333]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1801\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5881.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6268.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06584\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
epsin 2 isoform b; eps15 binding protein. [source:refseq;acc:nm\_014964]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1794\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5948.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6342.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06634\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
epsin 3. [source:refseq;acc:nm\_017957]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1809\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5816.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6196.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06535\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ergic-53 protein precursor (er-golgi intermediate compartment 53 kda protein) (lectin, mannose-binding 1) (gp58) (intracellular mannose specific lectin mr60). [source:swissprot;acc:p49257]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3177\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ero1-like. [source:refseq;acc:nm\_014584]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
855\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6562.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7242.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10352\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
erythroid differentiation and denucleation factor 1. [source:swissprot;acc:o60584]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2128\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5328.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5616.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05402\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
erythroid differentiation-related factor 1. [source:refseq;acc:nm\_015608]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3095\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
espin. [source:refseq;acc:nm\_031475]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1876\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6076.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6463.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0636\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
esterase d (ec 3.1.1.1). [source:swissprot;acc:p10768]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2250\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6834.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7153.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04677\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
estradiol 17 beta-dehydrogenase 1 (ec 1.1.1.62) (17-beta-hsd 1) (placental 17-beta-hydroxysteroid dehydrogenase) (20 alpha- hydroxysteroid dehydrogenase) (20-alpha-hsd) (e2dh). [source:swissprot;acc:p14061]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2520\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5964.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6113.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02511\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
estradiol 17 beta-dehydrogenase 4 (ec 1.1.1.62) (17-beta-hsd 4) (17-beta-hydroxysteroid dehydrogenase 4). [source:swissprot;acc:p51659]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2538\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7121.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7286.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02325\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
estrogen-related receptor gamma (estrogen receptor related protein 3) (err gamma-2). [source:swissprot;acc:o75454]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
902\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10246.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11285.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10147\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ethanolamine kinase (ec 2.7.1.82) (eki). [source:swissprot;acc:q9hbu6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2328\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6773.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7075.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04456\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/